| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. | Circulation | 2008 | 1.51 |
| 2 | Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation. | Am J Cardiol | 2010 | 1.03 |
| 3 | Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial. | Europace | 2012 | 0.83 |
| 4 | Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation in the Asia-Pacific region: a phase 3 randomized controlled trial. | J Cardiovasc Pharmacol | 2016 | 0.75 |